Imperial Innovations is the famous VC, which was founded in 1986. The company was established in Europe in United Kingdom. The main department of described VC is located in the London.
The real fund results show that this VC is 26 percentage points more often commits exit comparing to other companies. The high activity for fund was in 2016. The usual things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2013. The fund is generally included in 2-6 deals every year. Comparing to the other companies, this Imperial Innovations performs on 15 percentage points less the average number of lead investments.
We can highlight the next thriving fund investment areas, such as Health Diagnostics, Artificial Intelligence. For fund there is a match between the location of its establishment and the land of its numerous investments - United Kingdom. The fund has no exact preference in some founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. Among the most popular portfolio startups of the fund, we may highlight Cell Medica, Circassia, WaveOptics. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.
Besides them, we counted 8 critical employees of this fund in our database.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Imperial Innovations, startups are often financed by Nesta Ventures, Invesco, Sofinnova Partners. The meaningful sponsors for the fund in investment in the same round are Nesta Ventures, SV Health Investors, Woodford Investment Management. In the next rounds fund is usually obtained by Woodford Investment Management, Nesta Ventures, SV Health Investors.
Related Funds
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Resolver | $3M | 21 Oct 2016 | London, England, United Kingdom | ||
ThisWay | $2M | 27 Sep 2016 | Austin, Texas, United States | ||
Artios Pharma | $34M | 21 Sep 2016 | Cambridge, England, United Kingdom | ||
Oxular | $20M | 19 Jul 2016 | Oxford, Oxfordshire, United Kingdom | ||
Storm Therapeutics | $16M | 28 Jun 2016 | Cambridge, England, United Kingdom | ||
Inflowmatix | $4M | 26 May 2016 | Southampton, England, United Kingdom | ||
SAM Labs | $4M | 01 May 2016 | London, England, United Kingdom | ||
Oxular | $18M | 22 Feb 2016 | Oxford, Oxfordshire, United Kingdom | ||
Aqdot | $6M | 08 Feb 2016 | United Kingdom, England |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Resolver | $3M | 21 Oct 2016 | London, England, United Kingdom | ||
ThisWay | $2M | 27 Sep 2016 | Austin, Texas, United States | ||
Artios Pharma | $34M | 21 Sep 2016 | Cambridge, England, United Kingdom | ||
Oxular | $20M | 19 Jul 2016 | Oxford, Oxfordshire, United Kingdom | ||
Storm Therapeutics | $16M | 28 Jun 2016 | Cambridge, England, United Kingdom | ||
Inflowmatix | $4M | 26 May 2016 | Southampton, England, United Kingdom | ||
SAM Labs | $4M | 01 May 2016 | London, England, United Kingdom | ||
Oxular | $18M | 22 Feb 2016 | Oxford, Oxfordshire, United Kingdom | ||
Aqdot | $6M | 08 Feb 2016 | United Kingdom, England |